HuGE Literature Finder
Records
1
-
30
| Analysis of polymorphisms in genes associated with the FA/BRCA pathway in three patients with multiple primary malignant neoplasms. Artificial cells, nanomedicine, and biotechnology 2019 Dec 47 (1): 1101-1112. Wang Le, Wang Hao, Wang Ting, Liu Jinhui, Chen Wei, Wang Yamin, Chen Chao, Zhu Hongli, Dai Pengg |
| Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors. Journal of the National Comprehensive Cancer Network : JNCCN 2018 Mar 16 (3): 257-265. Zaid Mohammad Abu, Gathirua-Mwangi Wambui G, Fung Chunkit, Monahan Patrick O, El-Charif Omar, Williams Annalynn M, Feldman Darren R, Hamilton Robert J, Vaughn David J, Beard Clair J, Cook Ryan, Althouse Sandra K, Ardeshir-Rouhani-Fard Shirin, Dinh Paul C, Sesso Howard D, Einhorn Lawrence H, Fossa Sophie D, Travis Lois B, |
| Relationship between SRD5A2 rs9282858 polymorphism and the susceptibility of prostate cancer: A meta-analysis based on 20 publications. Medicine 2017 May 96 (19): e6791. Fang Cheng, Guo Zhong-Qiang, Chen Xiao-Yan, Liu Tong-Zu, Zeng Xian-Tao, Wang Xing-Hu |
| Association of Some Polymorphisms in the VDR Gene, CYP17 Gene and SRD5A2 Gene and Prostate Cancer among Lebanese
Men Asian Pacific journal of cancer prevention : APJCP 2017 01 18 (1): 93-100. El Ezzi Asmahan A, Baker Monika T, Zaidan Wissam R, Hraiki Kalim M, El Saidi Mohammad A, Kuddus Ruhul |
| Genotyping the High Altitude Mestizo Ecuadorian Population Affected with Prostate Cancer. BioMed research international 2017 2017 3507671. López-Cortés Andrés, Cabrera-Andrade Alejandro, Salazar-Ruales Carolina, Zambrano Ana Karina, Guerrero Santiago, Guevara Patricia, Leone Paola E, Paz-Y-Miño Cés |
| Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial. Cancer 2016 May . Price Douglas K, Chau Cindy H, Till Cathee, Goodman Phyllis J, Leach Robin J, Johnson-Pais Teresa L, Hsing Ann W, Hoque Ashraful, Parnes Howard L, Schenk Jeannette M, Tangen Catherine M, Thompson Ian M, Reichardt Juergen K V, Figg William |
| Systematic meta-analyses of gene-specific genetic association studies in prostate cancer. Oncotarget 2016 Mar . Hao Qiang, Wei Dong, Zhang Yaoguang, Chen Xin, Yang Fan, Yang Ze, Zhu Xiaoquan, Wang Jian |
| Single-nucleotide polymorphism in the 5-a-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors. European journal of cancer (Oxford, England : 1990) 2016 Jan 54 104-111. Boer Hink, Westerink Nico-Derk L, Altena Renske, Nuver Janine, Dijck-Brouwer D A Janneke, van Faassen Martijn, Klont Frank, Kema Ido P, Lefrandt Joop D, Zwart Nynke, Boezen H Marike, Smit Andries J, Meijer Coby, Gietema Jourik |
| Polymorphisms in androgen metabolism genes AR, CYP1B1, CYP19, and SRD5A2and prostate cancer risk and aggressiveness in Bulgarian patients. Turkish journal of medical sciences 2016 46 (3): 626-40. Kachakova Darina, Mitkova Atanaska, Popov Elenko, Beltcheva Olga, Vlahova Alexandrina, Dikov Tihomir, Christova Svetlana, Mitev Vanio, Slavov Chavdar, Kaneva Rad |
| Re: Single-Nucleotide Polymorphism in the 5-a-Reductase Gene (SRD5A2) is Associated with Increased Prevalence of Metabolic Syndrome in Chemotherapy-Treated Testicular Cancer Survivors. The Journal of urology 2016 12 196 (6): 1677-1678. Richie Jerome |
| The prognostic impact of serum testosterone during androgen-deprivation therapy in patients with metastatic prostate cancer and the SRD5A2 polymorphism. Prostate cancer and prostatic diseases 2016 06 19 (2): 191-6. Shiota M, Fujimoto N, Yokomizo A, Takeuchi A, Kashiwagi E, Dejima T, Kiyoshima K, Inokuchi J, Tatsugami K, Eto |
| Genetic variations in genes involved in testosterone metabolism are associated with prostate cancer progression: A Spanish multicenter study. Urologic oncology 2015 Jul 33 (7): 331.e1-7. Henríquez-Hernández Luis Alberto, Valenciano Almudena, Foro-Arnalot Palmira, Álvarez-Cubero María Jesús, Cozar José Manuel, Suárez-Novo José Francisco, Castells-Esteve Manel, Fernández-Gonzalo Pablo, De-Paula-Carranza Belén, Ferrer Montse, Guedea Ferrán, Sancho-Pardo Gemma, Craven-Bartle Jordi, Ortiz-Gordillo María José, Cabrera-Roldán Patricia, Rodríguez-Melcón Juan Ignacio, Herrera-Ramos Estefanía, Rodríguez-Gallego Carlos, Lara Pedro |
| The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population. Korean journal of urology 2015 Jan 56 (1): 19-30. Choi Se Young, Kim Hae Jong, Cheong Hyun Sub, Myung Soon Ch |
| Associations between the SRD5A2 gene V89L and TA repeat polymorphisms and breast cancer risk: a meta-analysis. Genetics and molecular research : GMR 2015 14 (3): 9004-12. Zhang D, Li Q, Qu H-C, Yu T, Liu Y |
| Genetic polymorphism in sex hormone metabolism and prostate cancer risk. Genetics and molecular research : GMR 2015 14 (3): 7326-34. Ersekerci E, Sofikerim M, Taheri S, Demirtas A, Halis |
| Genetic polymorphisms in the androgen metabolism pathway and risk of prostate cancer in low incidence Malaysian ethnic groups. International journal of clinical and experimental medicine 2015 8 (10): 19232-40. Poniah Prevathe, Mohamed Zahurin, Apalasamy Yamunah Devi, Mohd Zain Shamsul, Kuppusamy Shanggar, Razack Azad |
| SRD5A2 gene polymorphisms and the risk of benign prostatic hyperplasia but not prostate cancer. Asian Pacific journal of cancer prevention : APJCP 2015 16 (3): 1033-6. Choubey Vimal Kumar, Sankhwar Satya Narayan, Carlus S Justin, Singh Anand Narayan, Dalela Divakar, Thangaraj Kumarasamy, Rajender Sin |
| Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones. Human reproduction (Oxford, England) 2014 Dec 29 (12): 2844-51. Aschim E L, Oldenburg J, Kristiansen W, Giwercman A, Witczak O, Fosså S D, Haugen T |
| Polymorphism of the SRD5A2 gene and the risk of prostate cancer. Molecular medicine reports 2014 Dec 10 (6): 3151-6. Dušenka Róbert, Tomaškin Roman, Kliment Ján, Dobrota Dušan, Dušenková Svetlana, Vil?ková Marta, Sivo?ová Monika Kme?'o |
| Importance of 5a-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Feb 20 (3): 576-84. Lévesque Éric, Laverdière Isabelle, Lacombe Louis, Caron Patrick, Rouleau Mélanie, Turcotte Véronique, Têtu Bernard, Fradet Yves, Guillemette Chant |
| Relationship of early-onset baldness to prostate cancer in African-American men. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013 Apr 22 (4): 589-96. Zeigler-Johnson Charnita, Morales Knashawn H, Spangler Elaine, Chang Bao-Li, Rebbeck Timothy |
| Molecular markers in key steroidogenic pathways, circulating steroid levels, and prostate cancer progression. Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Feb 19 (3): 699-709. Lévesque Éric, Huang Shu-Pin, Audet-Walsh Étienne, Lacombe Louis, Bao Bo-Ying, Fradet Yves, Laverdière Isabelle, Rouleau Mélanie, Huang Chao-Yuan, Yu Chia-Cheng, Caron Patrick, Guillemette Chant |
| Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis. Molecular biology reports 2013 Jan . Li Q, Zhu Y, He J, Wang M, Zhu M, Shi T, Qiu L, Ye D, Wei Q |
| Variations in testosterone pathway genes and susceptibility to testicular cancer in Norwegian men. International journal of andrology 2012 Dec 35 (6): 819-27. Kristiansen W, Aschim E L, Andersen J M, Witczak O, Fosså S D, Haugen T |
| Androgen Metabolism Gene Polymorphisms, Associations with Prostate Cancer Risk and Pathological Characteristics: A Comparative Analysis between South African and Senegalese Men. Prostate cancer 2012 2012 . Fernandez P, Zeigler-Johnson CM, Spangler E, van der Merwe A, Jalloh M, Gueye SM, Rebbeck TR |
| Effectiveness of the combined evaluation of KLK3 genetics and free-to-total prostate specific antigen ratio for prostate cancer diagnosis. The Journal of urology 2012 Oct 188 (4): 1124-30. Zambon Carlo-Federico, Prayer-Galetti Tommaso, Basso Daniela, Padoan Andrea, Rossi Elisa, Secco Silvia, Pelloso Michela, Fogar Paola, Navaglia Filippo, Moz Stefania, Zattoni Filiberto, Plebani Mar |
| SRD5A polymorphisms and biochemical failure after radical prostatectomy. European urology 2011 Dec 60 (6): 1226-34. Audet-Walsh Etienne, Bellemare Judith, Nadeau Geneviève, Lacombe Louis, Fradet Yves, Fradet Vincent, Huang Shu-Pin, Bao Bo-Ying, Douville Pierre, Girard Hugo, Guillemette Chantal, Lévesque Er |
| Genotyping of sex hormone-related pathways in benign and malignant human prostate tissues: data of a preliminary study. Omics : a journal of integrative biology 2011 Jun 15 (6): 369-74. Balistreri Carmela Rita, Caruso Calogero, Carruba Giuseppe, Miceli Vitale, Candore Giuseppi |
| Meta-analysis of three polymorphisms in the steroid-5-alpha-reductase, alpha polypeptide 2 gene (SRD5A2) and risk of prostate cancer. Mutagenesis 2011 May 26 (3): 371-83. Li Xia, Huang Yan, Fu Xuping, Chen Chengwen, Zhang Deqiang, Yan Lili, Xie Yi, Mao Yanjun, Li Y |
| [V89L polymorphism of the testosterone 5-alpha-reductase II gene and prognostic factors of prostate cancer]. Zhonghua nan ke xue = National journal of andrology 2010 Nov 16 (11): 990-3. Tong Ming, Jin Yan-Yang, Li Gang, Liu Si-Ming, Ji Chun-Do |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jan 26, 2022
- Content source: